Get details from an obesity medicine specialist
The potential for increased fertility is a side effect
This is a synthetic tri-agonist peptide designed for laboratory research focused on multi-pathway metabolic signaling
Given alone, oestrogen has oncogenic potential, particularly in gynaecological tissues, precluding its use for metabolic purposes
Whilst retatrutide is not currently available in the UK outside of clinical trials, your GP can help you understand which licensed treatments may be appropriate for your individual circumstances, taking into account your medical history, current medications, and weight management goals
Other questions about the side effects of retatrutide Considering retatrutide for weight management brings up important questions about timing, costs, and safetyespecially when its still in trials